Two year vertebral fracture risk reduction with risedronate 35 mg once-a-week

被引：0
|
作者：
Watts, NB
Lindsay, R
Li, Z
Kasibhatla, C
Brown, J
机构：
[1] Procter & Gamble Pharmaceut, Cincinnati, OH USA
[2] Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY USA
[3] Univ Cincinnati, Bone Hlth & Ostroporosis Ctr, Cincinnati, OH USA
[4] CHUQ, Ctr Rech, Quebec City, PQ, Canada
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Vertebral fracture risk reduction over two years with risedronate 35 mg once-a-week
    Watts, NB
    Lindsay, R
    Li, Z
    Brown, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S40 - S40
  • [2] Once-a-week risedronate is effective in reducing vertebral fracture risk
    Brown, J
    Watts, WN
    Olszynski, W
    Adachi, JD
    [J]. JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1877 - 1877
  • [3] Efficacy of once-a-week risedronate in reducing vertebral fracture risk
    Watts, NB
    Li, Z
    Hoseyni, MS
    Seeman, E
    Lindsay, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S17 - S18
  • [4] Once-a-week (35 mg) risedronate is as effective as daily (5 mg)
    Lindsay, R
    Adachi, JD
    Emkey, RD
    Li, Z
    Balske, A
    Brown, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S16 - S16
  • [5] VERTEBRAL FRACTURE RISK REDUCTION WITH RISEDRONATE 150 MG ONCE-A-MONTH
    Watts, Nelson B.
    Klemes, Andrea B.
    Wagner, Leigh
    Brown, Jacques P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S211 - S211
  • [6] Once-a-week risedronate (Actonel)
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1141): : 87 - 88
  • [7] Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
    M. R. McClung
    P. D. Miller
    J. P. Brown
    J. Zanchetta
    M. A. Bolognese
    C. L. Benhamou
    A. Balske
    D. E. Burgio
    J. Sarley
    L. K. McCullough
    R. R. Recker
    [J]. Osteoporosis International, 2012, 23 : 267 - 276
  • [8] Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
    McClung, M. R.
    Miller, P. D.
    Brown, J. P.
    Zanchetta, J.
    Bolognese, M. A.
    Benhamou, C. L.
    Balske, A.
    Burgio, D. E.
    Sarley, J.
    McCullough, L. K.
    Recker, R. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 267 - 276
  • [9] EFFECT OF A DELAYED-RELEASE RISEDRONATE 35 MG ONCE-A-WEEK FORMULATION TAKEN WITH OR WITHOUT BREAKFAST ON BMD
    McClung, M. R.
    Zanchetta, J. R.
    Benhamou, C. L.
    Balske, A.
    Sarley, J.
    Recker, R. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 25 - 25
  • [10] A NOVEL DELAYED-RELEASE RISEDRONATE 35 MG ONCE-A-WEEK FORMULATION TAKEN WITH OR WITHOUT BREAKFAST: 2-YEAR BMD DATA
    Benhamou, Claude-Laurent
    Zanchetta, Jose
    Kaufman, Jean-Marc
    Brown, Jacques
    Maasalu, Katre
    Lakatos, Peter
    Badurski, Janusz
    Wenderoth, Dietrich
    McClung, Michael
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 337 - 338
12345